These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24331191)

  • 1. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
    Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
    Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
    Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
    Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
    Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
    Carver JR; Shapiro CL; Ng A; Jacobs L; Schwartz C; Virgo KS; Hagerty KL; Somerfield MR; Vaughn DJ;
    J Clin Oncol; 2007 Sep; 25(25):3991-4008. PubMed ID: 17577017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac testing to manage cardiovascular risk in cancer patients.
    Davis M; Witteles RM
    Semin Oncol; 2013 Apr; 40(2):147-55. PubMed ID: 23540740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
    Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
    Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced heart failure due to cancer therapy.
    Shah S; Nohria A
    Curr Cardiol Rep; 2015; 17(4):16. PubMed ID: 25687365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Heart Failure in Cancer Patients and Cancer Survivors.
    Finet JE
    Heart Fail Clin; 2017 Apr; 13(2):253-288. PubMed ID: 28279414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.
    Khakoo AY; Yeh ET
    Nat Clin Pract Oncol; 2008 Nov; 5(11):655-67. PubMed ID: 18797437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular complications of cancers and anti-cancer therapy].
    Vyskočil J; Petráková K; Jelínek P; Furdek M
    Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise recommendations for childhood cancer survivors exposed to cardiotoxic therapies: an institutional clinical practice initiative.
    Okada M; Meeske KA; Menteer J; Freyer DR
    J Pediatr Oncol Nurs; 2012; 29(5):246-52. PubMed ID: 22907680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk of symptomatic cardiac events in childhood cancer survivors.
    van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
    J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers.
    Chen MH; Colan SD; Diller L
    Circ Res; 2011 Mar; 108(5):619-28. PubMed ID: 21372293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.
    Adão R; de Keulenaer G; Leite-Moreira A; Brás-Silva C
    Rev Port Cardiol; 2013 May; 32(5):395-409. PubMed ID: 23623503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in cancer survivors.
    Okwuosa TM; Anzevino S; Rao R
    Postgrad Med J; 2017 Feb; 93(1096):82-90. PubMed ID: 28123076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
    Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
    Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardioprotective treatment during adjuvant cancer therapy].
    Gulati G; Heck SL; Ree AH; Gravdehaug B; Røsjø H; Steine K; Bratland Å; Hoffmann P; Geisler J; Omland T
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1832-6. PubMed ID: 24042297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular toxicities of cancer chemotherapy.
    Bonita R; Pradhan R
    Semin Oncol; 2013 Apr; 40(2):156-67. PubMed ID: 23540741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.